February 28, 2008
Celtic Catalysts wins "Rising Star Award"

Celtic Catalysts, a UCD chemistry spin-out company and a leading supplier of chiral products and technology to the Fine Chemical, Pharmaceutical and Biotech industrieswas declared the international winner of the “Rising Star Award” at the BioIndustry Association (Scotland) Thistle Bioscience Forum 2008 which took place earlier this month in Edinburgh.

Kevin Dalton, Sales Director and Dr Brian Kelly, CEO, Celtic Catalysts
Kevin Dalton, Sales Director and Dr Brian Kelly, CEO, Celtic Catalysts

Celtic Catalysts was among the four Irish biotech companies, all members of IBEC’s Irish BioIndustry Association (IBIA), who took part in the international “Rising Stars Showcase” competition along with 8 other companies from Scotland and Israel. Each of the participants pitched their companies and development strategies to a panel of experts and an invited audience before Celtic Catalysts was announced the overall winner after a confident and polished pitch by Kevin Dalton, Sales Director.

Celtic Catalysts’ focus is on the area of chiral synthesis and it has developed a comprehensive portfolio of intellectual property and carved out a uniquely strong niche for itself in the specialised area of P-chiral technology.  This technology can be used in the production of a range of drugs which are particularly prevalent in anti-viral and anti-cancer therapeutic areas.

Dr Brian Kelly and CSCB principal investigator Professor Declan Gilheany co-founded Celtic Catalysts in 2000 as a spin-out from UCD School of Chemistry and Chemical Biology. Celtic Catalysts currently employs a staff of 17 and is headquartered in NovaUCD, the Innovation and Technology Transfer Centre at UCD.

The IBIA is the leading representative body for the biotechnology industry in Ireland.  Celtic Catalysts and the three other Irish companies who took part in this competition, BiancaMed, which is also based in NovaUCD, EnBio and Luxcel Biosciences are all working on pioneering technologies which will ultimately improve the health and wellbeing of people all around the globe. 

 

More News